US Stock MarketDetailed Quotes

ARVN Arvinas

Watchlist
  • 7.720
  • +0.490+6.78%
Close May 2 16:00 ET
  • 7.650
  • -0.070-0.91%
Post 19:59 ET
563.49MMarket Cap-11.70P/E (TTM)

About Arvinas Company

Arvinas, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its product candidates are ARV-110, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer, ARV-471, and ARV-766, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer. The company was founded in February 2013 and is headquartered in New Haven, CT.

Company Profile

SymbolARVN
Company NameArvinas
Listing DateSep 27, 2018
Issue Price16.00
Founded2013
CEODr. John G. Houston, PhD
MarketNASDAQ
Employees430
Fiscal Year Ends12-31
Address5 Science Park,395 Winchester Avenue
CityNew Haven
ProvinceConnecticut
CountryUnited States of America
Zip Code06511
Phone1-203-535-1456

Company Executives

  • Name
  • Position
  • Salary
  • Dr. John G. Houston, PhD
  • Chairman of the Board, President and Chief Executive Officer
  • 12.75M
  • Randy Teel, PhD
  • Chief Business Officer
  • 3.78M
  • David Loomis
  • Vice President and Chief Accounting Officer
  • --
  • Andrew Saik
  • Chief Financial Officer and Treasurer
  • 3.47M
  • Dr. Noah Berkowitz, M.D.
  • Chief Medical Officer
  • 5.98M
  • Dr. Angela Cacace, PhD
  • Chief Scientific Officer
  • 2.97M
  • Dr. Ian Taylor, PhD
  • President, Research and Development
  • 4.22M
  • Linda C. Bain
  • Independent Director
  • 461.53K
  • Leslie V. Norwalk, Esq.
  • Independent Director
  • 451.53K
  • John Douglas Young
  • Independent Director
  • 451.07K
  • Everett V. Cunningham
  • Independent Director
  • 453.57K
  • Edward Kennedy, Jr
  • Independent Director
  • 451.53K
  • Dr. Sunil Agarwal, M.D.
  • Independent Director
  • 463.12K
  • Dr. Laurie Smaldone Alsup, M.D.
  • Independent Director
  • 456.53K
  • Dr. Briggs W. Morrison, M.D.
  • Lead Independent Director
  • 480.39K

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More